Mitsubishi UFJ Asset Management
AGIO icon

Mitsubishi UFJ Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-862
Closed -$66K – 919
2018
Q3 		$66K Sell
862
-90
-9% -$7.24K ﹤0.01% 894
2018
Q2 		$80K Sell
952
-86
-8% -$7.5K ﹤0.01% 814
2018
Q1 		$85K Buy
+1,038
New +$80.2K ﹤0.01% 800

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Mitsubishi UFJ Asset Management's AGIO Position: Q4 2018 in Review

Mitsubishi UFJ Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2018, closing a stake of 862 shares — an estimated $66K sold.

Mitsubishi UFJ Asset Management first reported a position in AGIO in Q1 2018 and held it in 3 quarters. The position peaked at $85K in Q1 2018. 196 funds tracked by Wall St. Rank hold AGIO as of Q4 2018.

  • Mitsubishi UFJ Asset Management reported no remaining Agios Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 862 Agios Pharmaceuticals shares in Q4 2018, an estimated $66K.
  • Mitsubishi UFJ Asset Management first reported a position in Agios Pharmaceuticals in Q1 2018 and held it in 3 quarters.
  • Mitsubishi UFJ Asset Management's Agios Pharmaceuticals position peaked at $85K in Q1 2018.
  • 196 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2018.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.